earnings
confidence high
sentiment positive
materiality 0.75
ICU Medical Q1 revenue up 7% to $605M; adjusted EPS $1.72 vs $0.96
ICU MEDICAL INC/DE
2025-Q1 EPS reported
-$0.63
revenue$604,702,000
- Revenue $604.7M, up 6.7% YoY from $566.7M.
- GAAP net loss $(15.5)M ($0.63 loss per share) vs $(39.5)M ($1.63 loss) YoY.
- Adjusted diluted EPS $1.72, up from $0.96 in Q1 2024.
- Adjusted EBITDA $99.4M vs $78.8M YoY, a 26% increase.
- GAAP gross margin expanded to 35% from 33% in prior year.